The Patent Finder
US

Oil-Based Foamable Carriers and Formulations

US 8,518,376 Term ended
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Dec 28, 2023 (SWK Funding LLC).

Term ended Apr 28, 2024 · High confidence

Filed Jul 18, 2011 as application 13/123,213 · Granted Aug 27, 2013
Base term, 20 years from filing · capped by a resolved terminal disclaimer
Today
20 years from filing
Term ended Apr 28, 2024
2009 2029
Clock starts
Oct 6, 2009
Term ended
Apr 28, 2024
Granted
Aug 27, 2013
base term after the term ends fee events Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 8,900,553.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
11
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. All three maintenance fees were paid, so no fee lapse ended it. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Oct 6, 2009, when application PCT/IB2009/007184, the earliest non-provisional in its chain, was filed (this one was filed Jul 18, 2011)Oct 6, 2029High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 8,900,553)capped to Apr 28, 2024High confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidterm endedHigh confidence
Computed term endThe steps above, in orderApr 28, 2024High confidence

Partial family

Application PCT/IB2008/003932PCT application
no patent term
no patent term
Application PCT/IB2008/003939PCT application
no patent term
no patent term
Application PCT/IB2009/007184PCT application
no patent term
no patent term
US 8,343,945In force
Dec 2028
Dec 2028
US 8,900,553Lapsed on the fee record
Dec 2022
Dec 2022
US 8,518,376this patent
Apr 2024
Apr 2024
US 9,161,916In force
Dec 2028
Dec 2028
US 9,795,564In force
Dec 2028
Dec 2028
8 of 11 applications in this family shown, earliest filings first. Partial: 4 of the 11 have no file history here, so a row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jul 18, 2011
Reel 26606, frame 188
Tamarkin, Dov; Schuz, David; Hazot, Yohan; Gazal, ElanaFoamix Ltd.Assignment of Assignor's Interest
Jul 30, 2014
Reel 33445, frame 249
Foamix Ltd.Foamix Pharmaceuticals Ltd.Change of Name
Jul 30, 2019
Reel 49912, frame 45
Foamix Pharmaceuticals Ltd.Perceptive Credit Holdings II, LPPatent Security Agreement
Nov 4, 2020
Reel 54306, frame 387
Foamix Pharmaceuticals Ltd.Vyne Pharmaceuticals Ltd.Change of Name
Feb 4, 2021
Reel 55215, frame 298
Vyne Pharmaceuticals Ltd.Vyne Therapeutics Inc.Assignment of Assignor's Interest
Feb 17, 2021
Reel 55326, frame 9
Vyne Therapeutics Inc.Perceptive Credit Holdings II, LPPatent Security Agreement
Sep 20, 2021
Reel 57544, frame 138
Perceptive Credit Holdings II, LPVyne Pharmaceuticals Ltd. (F/K/A Foamix Pharmaceuticals Ltd.)Release of Security Interest
Sep 20, 2021
Reel 57544, frame 708
Perceptive Credit Holdings II, LPVyne Therapeutics Inc. (F/K/A Menlo Therapeutics Inc. and Successor-in-Interest to Vyne Pharmaceuticals Ltd., F/K/A Foamix Pharmaceuticals Ltd.)Release of Security Interest
Dec 22, 2021
Reel 58463, frame 167
Vyne Therapeutics Inc.Vyne Pharmaceuticals Inc.Assignment of Assignor's Interest
Feb 1, 2022
Reel 58925, frame 568
Vyne Therapeutics Inc.; Vyne Pharmaceuticals Inc.Journey Medical CorporationAssignment of Assignor's Interest
Dec 28, 2023
Reel 66157, frame 79
Journey Medical Corporation; JG Pharma, Inc.SWK Funding LLCSecurity Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited